Abiomed Second Quarter Fiscal 2023 Earnings and Conference Call Notification

Rhea-AI Summary

Abiomed, Inc. (ABMD) will release its financial results for Q2 of fiscal year 2023 on November 1, 2022, with a conference call scheduled at 8:00 a.m. ET. CEO Michael R. Minogue and CFO Todd Trapp will host the call. Investors can listen via webcast or phone, with a replay available until November 8, 2022. Abiomed specializes in circulatory support and oxygenation technologies aimed at enhancing heart function and supporting respiratory health. The company emphasizes the importance of forward-looking statements subject to various risks.

Positive

• Scheduled release of Q2 financial results, indicating ongoing financial transparency.
• Conference call to discuss results, allowing investor engagement and insights.

Negative

• None.

DANVERS, Mass.--(BUSINESS WIRE)-- Abiomed, Inc. (NASDAQ: ABMD) announced that on Tuesday, November 1, 2022, the Company will release financial results for the second quarter of the fiscal year 2023. The Company will host a conference call to discuss the results on Tuesday, November 1, 2022 at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Todd Trapp, Chief Financial Officer, will host the conference call.

To listen to the call live, please tune into the webcast via https://events.q4inc.com/attendee/493387843 or dial (844) 200-6205; the international number is (929) 526-1599 access code 367357. A replay of this conference call will be available until Tuesday, November 8, 2022. The replay phone number is (866) 813- 9403; the international number is +44 204 525 0658.

ABOUT ABIOMED
Based in Danvers, Massachusetts, USA, Abiomed (ABMD), is a leading provider of medical technology that provides circulatory support and oxygenation. Our products are designed to enable the heart to rest by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit: www.abiomed.com.

FORWARD-LOOKING STATEMENTS

Any forward-looking statements are subject to risks and uncertainties such as those described in Abiomed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221013005232/en/

For further information, please contact:

Todd Trapp

Chief Financial Officer

978-646-1680

ttrapp@abiomed.com

Source: Abiomed, Inc.

FAQ

When will Abiomed release Q2 financial results for fiscal year 2023?

Abiomed will release its Q2 financial results on November 1, 2022.

What time is the conference call for Abiomed's Q2 financial results?

The conference call is scheduled for 8:00 a.m. ET on November 1, 2022.

Who will host the conference call for Abiomed's Q2 results?

The conference call will be hosted by CEO Michael R. Minogue and CFO Todd Trapp.

How can I listen to the Abiomed conference call?

You can listen to the call live via webcast or by dialing 844-200-6205; international callers can dial 929-526-1599.

Is there a replay available for the Abiomed conference call?

Yes, a replay will be available until November 8, 2022.